Clinical Trials Logo

Clinical Trial Summary

Spondyloarthritis (SpA) is a type of chronic inflammatory rheumatic disease that mainly affects the spine and peripheral joints, or joints, ligaments and tendons. This disease subtype has the same clinical and immunological features. Further explore the pathogenesis of spondyloarthritis, explore the guiding significance of different imaging examinations for spondyloarthritis, and study the efficacy and mechanism of different drugs for spondyloarthritis.


Clinical Trial Description

1. Clinical phenotype research. The clinical phenotype is the symptoms and signs of the disease and its evolution. Through the clinical phenotype research of spondyloarthritis, it is helpful to realize the diagnosis and grading of spondyloarthritis and help to achieve individualization Precise treatment. 2. Transcriptomic research. The key genes and pathways involved in the pathogenesis of spondyloarthritis can be explored through transcriptomic research of spondyloarthritis, which can provide help for early diagnosis and seeking potential treatment methods. 3. Microbiological research. Through the microbiome research on spondyloarthritis, the composition and function of intestinal flora in patients with spondyloarthritis can be deeply analyzed to provide help for diagnosis and treatment. 4. Radiomics research. Through the radiomics research on spondyloarthritis, it is helpful to realize the diagnosis and grading of spondyloarthritis and the evaluation and prediction of treatment. 5. Drug treatment research By studying the therapeutic effects of different drugs in patients with spondyloarthritis, it is helpful to explore the efficacy and mechanism of different drugs on spondyloarthritis, and to achieve precise and individualized treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05494203
Study type Observational
Source First Affiliated Hospital of Wenzhou Medical University
Contact
Status Enrolling by invitation
Phase
Start date September 2022
Completion date July 2023

See also
  Status Clinical Trial Phase
Completed NCT03818958 - Seric Calprotectine in Spondyloarthritis
Completed NCT01947465 - Immunogenicity and Safety of Vaccinations in Immunocompromised Persons N/A
Recruiting NCT05926453 - Assessment of Cardiorespiratory Fitness in Spondylarthritis
Recruiting NCT05080218 - COVID-19 VaccinE Response in Rheumatology Patients Phase 4
Terminated NCT03454932 - Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
Completed NCT01314547 - Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort N/A
Not yet recruiting NCT06273306 - Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IMIDOC) N/A
Recruiting NCT02809781 - A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis Phase 2/Phase 3
Completed NCT02098694 - Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis N/A
Recruiting NCT00491933 - Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists N/A
Enrolling by invitation NCT04964661 - Incidence of MRI Sacro-Iliac (SI) Joint Anomalies in Women With Spondyloarthritis (SpA)
Completed NCT02473315 - Assessment of Whole Body Cryotherapy in Treatment of Active Axial Spondylarthritis N/A
Completed NCT03999489 - Study of the Psychometric Properties and a Measure of Utility Determinants ( the SF- 6D) in Patients With Early Inflammatory Low Back Pain
Recruiting NCT04519866 - Clinical Trial of Electroacupuncture in Axial Spondyloarthritis (E-AcuSpA) N/A
Completed NCT02402894 - Follow-up of Person-centered Care of Young Adults With Rheumatic Disease
Recruiting NCT05592574 - IL17 Rate and Spondyloarthritis
Completed NCT02988674 - A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation
Recruiting NCT05555433 - Calprotectine in Spondyloarthritis
Recruiting NCT06460805 - axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis N/A
Completed NCT01302730 - Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study N/A